Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

INTI

Inhibitor Therapeutics, Inc.

CIK 0001042418 · OTC

OTCHealth CarePharmaceutical Preparations
$0.08
↑ 0.00 (0.00%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Overall read: BullishOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$13.55M
P/E Ratio
-4.04
EPS
-0.02
Dividend Yield
Not covered
52W Position
49%
Beta
-0.26

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-6.85
P/S
Not covered
EV/Revenue
Not covered
ROE
169.5%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 49%
$0.04$0.12

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$3.30M
Total Assets
$2.51M
Free Cash Flow
–

Recent news